Bank Of New York Mellon Corp Fibrogen Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$15.95 - $25.18 $4.56 Million - $7.2 Million	286,015 New	286,015 $5.34 Billion
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $3.92 Million - $5.23 Million	295,252 New	295,252 $4.73 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $348,167 - $445,898	30,541 Added 11.38%	298,870 $3.89 Million
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $99,512 - $162,427	-12,533 Reduced 4.46%	268,329 $2.83 Million
Q1 2022 May 11, 2022	BUY	$12.02 - $16.79 $36,084 - $50,403	3,002 Added 1.08%	280,862 $3.38 Million
Q4 2021 Feb 11, 2022	SELL	$9.93 - $15.39 $755,563 - $1.17 Million	-76,089 Reduced 21.5%	277,860 $3.92 Million
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $18.1 Million - $47.5 Million	-1,781,469 Reduced 83.42%	353,949 $3.62 Million
Q2 2021 Aug 11, 2021	SELL	$18.57 - $35.68 $3.65 Million - $7.01 Million	-196,480 Reduced 8.43%	2,135,418 $56.9 Million
Q1 2021 May 13, 2021	BUY	$31.0 - $55.72 $16.9 Million - $30.3 Million	544,562 Added 30.47%	2,331,898 $80.9 Million
Q4 2020 Feb 09, 2021	BUY	$37.09 - $48.97 $6.75 Million - $8.91 Million	182,030 Added 11.34%	1,787,336 $66.3 Million
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $3.81 Million - $4.28 Million	94,119 Added 6.23%	1,605,306 $66 Million
Q2 2020 Aug 12, 2020	BUY	$32.57 - $42.83 $13.4 Million - $17.6 Million	410,253 Added 37.26%	1,511,187 $61.2 Million
Q1 2020 May 06, 2020	SELL	$23.3 - $45.96 $975,780 - $1.92 Million	-41,879 Reduced 3.66%	1,100,934 $38.3 Million
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $6.95 Million - $9.66 Million	200,984 Added 21.34%	1,142,813 $49 Million
Q3 2019 Nov 07, 2019	SELL	$36.98 - $48.45 $144,813 - $189,730	-3,916 Reduced 0.41%	941,829 $34.8 Million
Q2 2019 Aug 12, 2019	BUY	$35.13 - $55.53 $5.32 Million - $8.41 Million	151,529 Added 19.08%	945,745 $42.7 Million
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $8.62 Million - $12.1 Million	201,319 Added 33.96%	794,216 $43.2 Million
Q4 2018 Feb 11, 2019	BUY	$37.97 - $60.16 $9.78 Million - $15.5 Million	257,530 Added 76.79%	592,897 $27.4 Million
Q3 2018 Nov 09, 2018	SELL	$56.3 - $67.25 $119,187 - $142,368	-2,117 Reduced 0.63%	335,367 $0
Q2 2018 Aug 06, 2018	SELL	$44.9 - $64.95 $186,424 - $269,672	-4,152 Reduced 1.22%	337,484 $21.1 Million
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $387,289 - $526,491	8,540 Added 2.56%	341,636 $15.8 Million
Q4 2017 Feb 09, 2018	BUY	$41.95 - $60.1 $14 Million - $20 Million	333,096	333,096 $15.8 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account